Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer
BackgroundThe natural killer (NK) activity of peripheral blood mononuclear cells (PBMCs) is a crucial defense against the onset and spread of cancer. Studies have shown that patients with reduced NK activity are more susceptible to cancer, and NK activity tends to decrease due to cancer-induced immu...
Saved in:
| Main Authors: | Vladimir Rogovskii, Vladimir V. Murugin, Nikolay Vorobyev, Sergey Popov, Nikolay Sturov, Alexey Krasheninnikov, Alexander Morozov, Marina Prokhorova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1503317/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy
by: Alba Rodríguez-García, et al.
Published: (2025-02-01) -
Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges
by: Qiang Zhang, et al.
Published: (2025-06-01) -
Urolithins’ interaction with hepatocyte growth factor receptor: a mechanistic basis for anticancer activity in gastric adenocarcinoma cells
by: Fatemehsadat Hosseini, et al.
Published: (2025-05-01) -
Emerging evidence of Urolithin A in sports nutrition: bridging preclinical findings to athletic applications
by: Manda Wang, et al.
Published: (2025-05-01) -
Urolithin A Attenuates Periodontitis in Mice via Dual Anti-Inflammatory and Osteoclastogenesis Inhibition: A Natural Metabolite-Based Therapeutic Strategy
by: Yishu Xia, et al.
Published: (2025-07-01)